Synapse - A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers

A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers Meeting Abstract

Authors:	Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C.; Chan, D.; Myers, M.; Makhnin, A.; Jain, H.; Martinez, A.; Iqbal, Z.; Adamski, A.; Li, H.; Hernandez, J.; Watford, S.; Hosseini, A.; Shaffer, T.; Lim, L.; Li, M.; Drilon, A.; Ladanyi, M.; Arcila, M.; Rusch, V.; Jones, D.; Rudin, C.; Rimner, A.; Isbell, J.; Li, B.
Abstract Title:	A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
Meeting Title:	20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords:	non-small cell lung cancer; liquid biopsy; uncommon driver mutation
Journal Title:	Journal of Thoracic Oncology
Volume:	14
Issue:	10 Suppl.
Meeting Dates:	2019 Sept 7-10
Meeting Location:	Barcelona, Spain
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2019-10-01
Start Page:	S410
Language:	English
ACCESSION:	WOS:000492162202166
DOI:	10.1016/j.jtho.2019.08.837
PROVIDER:	wos
Notes:	Meeting Abstract: P1.01-122 -- Source: Wos